An aspect of lifecycle management is to expand the geographic commercial reach of the drug by considering effective approaches to ensure patient access. For example, Early Access Programs can be immensely useful in early market penetration leading to increased acceptance by physicians and patients after the commercial launch of the product. If you require critical thinking on the development of operating models that allow expanded commercial reach at various lifecycle stages, I look forward to hearing from you!
Jill Jobbins Advisory 